Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,470.00    0.00 (0.00%)
Bid:
5,440.00
Ask:
5,470.00
Spread: 30.00 (0.551%)
Market Cap: £2.93b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

Director/PDMR Shareholding

22 Dec 2025 11:33

RNS Number : 4967M
Cranswick PLC
22 December 2025
 

Director Shareholdings

Cranswick plc ("the Company")

The Company has been notified that the following award of options has been made on 22 December 2025, pursuant to the Cranswick plc Save As You Earn ("SAYE") share scheme (the "Scheme"), to certain Directors over ordinary shares of 10 pence each in the Company ("Ordinary Shares"), as follows:

Director

No. of Ordinary Shares under Option

Option Price

Option Duration

Christopher Alderley

374

4,110 pence

5 years

James Brisby

374

4,110 pence

5 years

Adam Couch

616

4,110 pence

5 years

 

Eligible employees were invited to subscribe for options over Ordinary Shares at an exercise price of 4,110 pence, representing a 20% discount to the average closing middle market price of an ordinary share over the three dealing days before the invitation to participate was made on 2 December 2025.

The following notifications provide details of the options granted to Persons Discharging Managerial Responsibility (PDMRs).

 

 

Enquiries:

Steven Glover, Company Secretary tel: 01482 275000

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Christopher Aldersley

2

Reason for the notification

a)

Position/status

Director

b)

Initial notification/amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cranswick plc

b)

LEI

549300LDZLPU51XOSK43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10 pence each 

GB0002318888

b)

Nature of the transaction

Grant of SAYE Options

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Grant of SAYE Options

4,110p

374

d)

Aggregated information

- Aggregated volume 

- Price

- Purpose

 

n/a

n/a

Option Grant

e)

Date of the transaction

22 December 2025

f)

Place of the transaction

Outside a trading venue

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

James Robert Brisby

2

Reason for the notification

a)

Position/status

Director

b)

Initial notification/amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cranswick plc

b)

LEI

549300LDZLPU51XOSK43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10 pence each 

GB0002318888

b)

Nature of the transaction

Grant of SAYE Options

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Grant of SAYE Options

4,110p

374

d)

Aggregated information

- Aggregated volume 

- Price

- Purpose

 

n/a

n/a

Option Grant

e)

Date of the transaction

22 December 2025

f)

Place of the transaction

Outside a trading venue

 

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Adam Hartley Couch

2

Reason for the notification

a)

Position/status

Director

b)

Initial notification/amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cranswick plc

b)

LEI

549300LDZLPU51XOSK43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10 pence each 

GB0002318888

b)

Nature of the transaction

Grant of SAYE Options

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Grant of SAYE Options

4,110p

616

d)

Aggregated information

- Aggregated volume 

- Price

- Purpose

 

n/a

n/a

Option Grant

e)

Date of the transaction

22 December 2025

f)

Place of the transaction

Outside a trading venue

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAFAAADFSFFA
Date   Source Headline
30th Jul 20187:00 amRNSFirst quarter trading statement
26th Jul 20183:17 pmRNSDividend Declaration
23rd Jul 201812:08 pmRNSHolding(s) in Company
9th Jul 20183:53 pmRNSHolding(s) in Company
2nd Jul 201811:01 amRNSTotal Voting Rights
8th Jun 20181:07 pmRNSDirector/PDMR Shareholding
5th Jun 20184:42 pmRNSHolding(s) in Company
1st Jun 20182:39 pmRNSTotal Voting Rights
29th May 20181:53 pmRNSHolding(s) in Company
25th May 201811:32 amRNSDirector/PDMR Shareholding
25th May 201811:30 amRNSDirector/PDMR Shareholding
22nd May 20187:00 amRNSPreliminary Results
3rd May 201811:26 amRNSTotal Voting Rights
18th Apr 20184:49 pmRNSDirector/PDMR Shareholding
3rd Apr 20189:41 amRNSBlock listing Interim Review
3rd Apr 20189:36 amRNSBlock listing Interim Review
3rd Apr 20189:34 amRNSTotal Voting Rights
13th Mar 20182:22 pmRNSDirector/PDMR Shareholding
13th Mar 20181:59 pmRNSDirector/PDMR Shareholding
5th Mar 20187:00 amRNSDirectorate Change
2nd Mar 201810:00 amRNSTotal Voting Rights
14th Feb 201811:03 amRNSDirector/PDMR Shareholding
13th Feb 201812:13 pmRNSDirector/PDMR Shareholding
13th Feb 201812:08 pmRNSDirector/PDMR Shareholding
1st Feb 20189:58 amRNSTotal Voting Rights
1st Feb 20187:00 amRNSThird Quarter Trading Statement
29th Jan 20183:57 pmRNSHolding(s) in Company
29th Jan 20182:14 pmRNSDirector/PDMR Shareholding
29th Jan 20182:13 pmRNSDirector/PDMR Shareholding
29th Jan 20182:13 pmRNSDirector/PDMR Shareholding
26th Jan 20189:36 amRNSDirector/PDMR Shareholding
26th Jan 20189:36 amRNSDirector/PDMR Shareholding
24th Jan 20189:54 amRNSAdditional Listing
19th Jan 201811:40 amRNSDirector/PDMR Shareholding
17th Jan 201810:45 amRNSDirector/PDMR Shareholding
17th Jan 201810:45 amRNSDirector/PDMR Shareholding
9th Jan 20189:02 amRNSDirector/PDMR Shareholding
2nd Jan 201812:23 pmRNSTotal Voting Rights
14th Dec 20172:52 pmRNSDividend Declaration
4th Dec 201711:47 amRNSTotal Voting Rights
28th Nov 20177:00 amRNSHalf-year Report
2nd Nov 20172:00 pmRNSTotal Voting Rights
25th Oct 201710:01 amRNSBlock listing Interim Review
25th Oct 201710:01 amRNSBlock listing Interim Review
2nd Oct 20179:24 amRNSTotal Voting Rights
21st Sep 20174:31 pmRNSDirector/PDMR Shareholding
14th Sep 20171:52 pmRNSDirector/PDMR Shareholding
14th Sep 20179:15 amRNSHolding(s) in Company
5th Sep 201711:50 amRNSDirector/PDMR Shareholding
5th Sep 201711:50 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.